Retaron-I is a product/ingredient name recorded in India's Food Safety and Standards Authority of India (FSSAI) documentation under the non-specified food and food ingredient regulatory framework. Public FSSAI records associate Retaron-I with M/s Anphar Organics Pvt. Ltd., Jammu, under application/file reference 72/Std/PA/FSSAI/2018, dated 14 January 2020.
For manufacturers, formulators, distributors, and procurement teams researching Retaron-I, it is important to distinguish the product name from similarly named commercial products available in other markets. Public regulatory information currently available for Retaron-I does not provide a complete standardized chemical specification such as a CAS number, molecular formula, molecular weight, HPLC assay, or pharmacopoeial monograph.
Retaron-I is identified in FSSAI's public records as a product/ingredient application associated with Anphar Organics Pvt. Ltd. The application was submitted under the Food Safety and Standards framework for non-specified food and food ingredients.
The publicly available regulatory record establishes the identity of the application and its applicant, but does not provide sufficient technical information to accurately describe Retaron-I as a single defined chemical compound. Therefore, detailed technical specifications should be obtained from the relevant manufacturer, applicant, or an authorized supplier before commercial procurement or formulation.
Retaron-I may be of interest to companies involved in nutraceutical, food ingredient, formulation, ingredient sourcing, and product-development research. Before using any material marketed under this name, buyers should verify the exact product identity, composition, intended application, regulatory status, specifications, and supporting quality documentation.
For commercial sourcing, it is recommended to request documentation such as:
According to FSSAI's published records, Retaron-I was associated with application reference 72/Std/PA/FSSAI/2018, dated 14 January 2020, with M/s Anphar Organics Pvt. Ltd., Jammu listed as the applicant.
FSSAI's February 2026 publication lists Retaron-I in its Closed / Withdrawn applications under the Food Safety and Standards (Approval for Non-Specified Food and Food Ingredients) Regulations, 2017.
This regulatory information is important for companies evaluating Retaron-I for commercial applications in India. Regulatory status should always be independently verified against the latest applicable FSSAI requirements before introducing an ingredient into a food, nutraceutical, or other regulated formulation.
For industrial procurement, technical documentation is essential. A supplier should be able to provide product-specific documentation confirming the identity and quality of the material being supplied.
Depending on the intended application, documentation may include identity testing, assay or active-marker testing, moisture or loss-on-drying results, microbiological testing, heavy-metal analysis, residual-solvent analysis, and other relevant quality parameters.
Because publicly available sources do not establish a universal Retaron-I specification, product-specific CoA and specification documentation should be used instead of assuming generic API or pharmacopoeial specifications.
Companies searching for Retaron-I suppliers in India, Retaron-I ingredient manufacturers, Retaron-I exporters, or Retaron-I bulk suppliers should verify that the material supplied corresponds exactly to the requested product or ingredient.
Product name similarity can sometimes create confusion between different ingredients, proprietary blends, branded formulations, and regulatory applications. Buyers should therefore confirm:
Reliable sourcing is particularly important for specialized ingredients for which publicly available technical information may be limited. A professional supplier should provide transparent product information and documentation before commercial supply.
Mediocon can assist pharmaceutical, nutraceutical, food, cosmetic, and ingredient companies with ingredient sourcing, technical documentation, bulk procurement, and customized supply requirements, subject to product availability and applicable regulatory requirements.
For organizations evaluating Retaron-I for research, formulation development, or commercial procurement, bulk supply requirements should be discussed based on the exact material specification and intended application.
Bulk orders can be evaluated according to:
Mediocon provides sourcing and supply support for a broad range of pharmaceutical ingredients, nutraceutical ingredients, specialty ingredients, and related materials.
For Retaron-I, customers should provide their required specification or product documentation so that the exact material can be verified before quotation and supply.
Contact Mediocon for Retaron-I product availability, technical documentation, bulk sourcing, and commercial requirements.
| Parameter | Specification |
|---|---|
| Appearance | As per specification |
| Identification | Product-specific identification testing; refer to current manufacturer specification and CoA. |
| Loss on Drying | As per specification |
| Heavy Metals | Product-specific specification; verify by current CoA |
| pH (1% Solution) | As per specification |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Retaron-I | Nutraceutical Ingredient Supplier & Manufacturer in India (CAS N/A) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Retaron-I | Nutraceutical Ingredient Supplier & Manufacturer in India is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance